Testing effectiveness (Phase 2)Study completedNCT00045734
What this trial is testing
Imatinib Mesylate in Treating Patients With Recurrent Meningioma
Who this might be right for
Adult Grade I MeningiomaAdult Grade II MeningiomaAdult Grade III Meningioma+3 more
National Cancer Institute (NCI) 23